# Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

> **NCT02606851** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1000 (actual)

## Conditions studied

- Patients With Typical Symptoms of GERD (GERD Q >= 8)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02606851
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-04
- **Primary completion:** 2016-12-28
- **Final completion:** 2016-12-28
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02606851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02606851, "Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02606851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*